Exagen Investor Relations Material
Latest events
Q1 2025
Exagen
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Exagen Inc
Access all reports
Exagen Inc. is a life sciences company focused on transforming the diagnosis, prognosis, and management of autoimmune diseases. The company develops and commercializes advanced diagnostic solutions designed to provide actionable insights for physicians treating conditions such as lupus and rheumatoid arthritis. Exagen’s product portfolio includes proprietary tests and services that integrate genomic and proteomic technologies to support personalized patient care. The company is headquartered in Vista, California, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
XGN
Country
🇺🇸 United States